Torigen Pharmaceuticals' Seed VC Round

Torigen Pharmaceuticals raised a round of funding on April 21, 2017. Investors include UCONN Ventures.

Torigen Pharmaceuticals is commercializing a revolutionary veterinary cancer treatment for companion animals using the animals' existing tumor cells to fight the disease. Called VetiVax, the product i…

Articles about Torigen Pharmaceuticals' Seed VC Round: